Vaccine Status and Hypogammaglobulinemia in N-MOmentum Trial Analyses NeurologyLive 2:55 1 year ago 275 Далее Скачать
Bruce Cree, MD, PhD, MAS: Insights from the N-MOmentum Study of Inebilizumab NeurologyLive 3:46 4 years ago 143 Далее Скачать
Inebilizumab in AQP4+ NMOSD patients with history of immunosuppression treatment: N-MOmentum study VJNeurology 1:56 1 year ago 90 Далее Скачать
MRI data from N-MOmentum: impact of inebilizumab on subclinical spinal lesions in NMOSD VJNeurology 6:31 11 months ago 85 Далее Скачать
Updates on N-MOmentum: inebilizumab versus placebo in patients with NMOSD VJNeurology 2:44 3 years ago 100 Далее Скачать
Recent updates from the MOMENTUM trial and the value of momelotinib for the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 1:53 2 years ago 119 Далее Скачать
Long Term Benefits of Inebilizumab Revealed in N MOmentum Analysis NeurologyLive 4:04 1 year ago 124 Далее Скачать
An insight into the MOMENTUM trial: safety and efficacy of momelotinib for the treatment of MF VJHemOnc – Video Journal of Hematology & HemOnc 3:03 2 years ago 367 Далее Скачать
Strategic promotions for product trials first 30 days on Shelf Talks Podcast Shelf Talks Podcast 0:56 2 days ago 206 Далее Скачать
Inebilizumab Treatment in Newly Diagnosed NMOSD Patients CheckRare 5:43 2 years ago 702 Далее Скачать
Updated results from the MOMENTUM trial VJHemOnc – Video Journal of Hematology & HemOnc 2:48 1 year ago 175 Далее Скачать
InMomentum - Two Levels of Pure Time-Trial Gameplay Digital Arrow 2:55 13 years ago 72 494 Далее Скачать
Global Dynamics for the Last Chapter of 2024 | Sudden Turns in Momentum Lead to New Visions Esoteric Sky 45:41 5 days ago 7 023 Далее Скачать
Efficacy of inebilizumab in patients with NMOSD with Fc receptor III-A polymorphisms VJNeurology 5:12 2 years ago 153 Далее Скачать
AAN 2021 Highlights: Two-Year Efficacy and Safety Data with Inebilizumab To Treat NMOSD CheckRare 3:22 3 years ago 204 Далее Скачать
